Symbols / VIR Stock $10.35 -3.00% Vir Biotechnology, Inc.

Healthcare • Biotechnology • United States • NMS
VIR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally. Its clinical development pipeline consists of product investigational therapies targeting hepatitis delta virus (HDV) and other solid tumors. The company's preclinical candidates include those targeting influenza A and B antibodies and antibody drug conjugates, and coronavirus monoclonal antibodies; and PRO-XTEN, a dual-masked TCEs targeting variety of solid tumors. It has grant collaboration and license agreement with Astellas; license agreement with Norgine for the treatment of CHD; amended and restated letter agreement with the Gates Foundation; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreement with the Institute for Research in Biomedicine; a license agreement with The Rockefeller University; license agreements with Xencor; and a collaborative research agreement with GlaxoSmithKline Biologicals S.A. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.

Stock Fundamentals
Scroll to Statements
Market Cap 1.67B Enterprise Value 1.12B Income -437.99M Sales 68.56M Book/sh 5.49 Cash/sh 3.35
Dividend Yield — Payout 0.00% Employees 367 IPO — P/E — Forward P/E -4.60
PEG — P/S 24.34 P/B 1.89 P/C — EV/EBITDA -2.45 EV/Sales 16.33
Quick Ratio 5.07 Current Ratio 5.54 Debt/Eq 12.79 LT Debt/Eq — EPS (ttm) -3.16 EPS next Y -2.25
EPS Growth — Revenue Growth 4.18% Earnings 2026-05-06 ROA -24.36% ROE -45.73% ROIC —
Gross Margin 0.00% Oper. Margin -74.92% Profit Margin 0.00% Shs Outstand 161.23M Shs Float 102.83M Short Float 15.72%
Short Ratio 5.35 Short Interest — 52W High 11.66 52W Low 4.16 Beta 1.66 Avg Volume 3.53M
Volume 1.21M Target Price $20.78 Recom Strong_buy Prev Close $10.67 Price $10.35 Change -3.00%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$20.78
Mean price target
2. Current target
$10.35
Latest analyst target
3. DCF / Fair value
$-19.47
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$10.35
Low
$17.00
High
$30.00
Mean
$20.78

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-04 main HC Wainwright & Co. Buy → Buy $20
2026-02-25 main Barclays Overweight → Overweight $30
2026-02-24 main Morgan Stanley Overweight → Overweight $24
2026-02-24 main Evercore ISI Group Outperform → Outperform $18
2026-02-24 main Needham Buy → Buy $18
2026-02-09 reit Needham Buy → Buy $14
2025-12-30 reit HC Wainwright & Co. Buy → Buy $15
2025-09-15 reit HC Wainwright & Co. Buy → Buy $15
2025-09-03 init Evercore ISI Group — → Outperform $12
2025-08-27 up B of A Securities Neutral → Buy $14
2025-07-11 init Raymond James — → Outperform $12
2025-05-22 reit Needham Buy → Buy $14
2025-05-12 main Needham Buy → Buy $14
2025-04-17 main Goldman Sachs Buy → Buy $21
2025-02-28 main Barclays Overweight → Overweight $31
2025-02-28 reit HC Wainwright & Co. Buy → Buy $110
2025-02-27 reit Needham Buy → Buy $19
2025-01-31 reit HC Wainwright & Co. Buy → Buy $110
2025-01-13 main Leerink Partners Outperform → Outperform $20
2025-01-10 reit HC Wainwright & Co. Buy → Buy $110
News
RSS: Latest VIR news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-06 DE BACKER MARIANNE Chief Executive Officer — 72,559 $9.16 $664,350
2026-04-01 SATO VICKI LEE Director — 22,000 $9.07 $199,617
2026-03-23 SABATINI BRENT Officer — 7,711 $9.12 $70,324
2026-03-02 SATO VICKI LEE Director — 22,000 $9.50 $209,181
2026-02-25 DE VERNEUIL VANINA ALEXANDRA HUARD General Counsel — 16,817 $9.53 $164,247
2026-02-25 EISNER MARK E Officer — 3,505 $9.53 $33,955
2026-02-24 DE BACKER MARIANNE Chief Executive Officer — 14,762 $9.53 $140,720
2026-02-24 O'BYRNE JASON Chief Financial Officer — 1,634 $9.53 $15,576
2026-02-24 SABATINI BRENT Officer — 1,430 $9.53 $13,632
2026-02-24 SATO VICKI LEE Director — 42,377 $9.75 $413,366
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
66.52
+4.41%
63.71
+61.32%
39.49
-97.50%
1,580.47
Operating Revenue
63.13
+2.87%
61.37
+64.17%
37.38
-97.63%
1,580.47
Cost Of Revenue
0.03
-96.92%
0.84
-69.44%
2.77
-98.11%
146.32
Reconciled Cost Of Revenue
0.03
-96.92%
0.84
-69.44%
2.77
-98.11%
146.32
Gross Profit
66.49
+5.77%
62.87
+71.16%
36.73
-97.44%
1,434.15
Operating Expense
546.00
-11.22%
615.04
-13.07%
707.48
+17.70%
601.09
Research And Development
455.97
-9.98%
506.50
-12.63%
579.72
+22.14%
474.65
Selling General And Administration
92.07
-22.65%
119.03
-31.76%
174.44
+7.84%
161.76
Other Operating Expenses
-2.04
+80.60%
-10.49
+77.52%
-46.69
-32.16%
-35.33
Total Expenses
546.03
-11.34%
615.88
-13.29%
710.24
-4.97%
747.40
Operating Income
-479.51
+13.16%
-552.17
+17.68%
-670.75
-180.52%
833.07
Total Operating Income As Reported
-479.33
+18.37%
-587.16
+14.20%
-684.30
-182.14%
833.07
EBITDA
-467.83
+12.98%
-537.61
+17.46%
-651.29
-177.55%
839.85
Normalized EBITDA
-469.74
+5.50%
-497.09
+19.28%
-615.85
-164.76%
950.99
Reconciled Depreciation
11.68
-19.77%
14.56
-25.15%
19.45
+186.76%
6.78
EBIT
-479.51
+13.16%
-552.17
+17.68%
-670.75
-180.52%
833.07
Total Unusual Items
1.91
+104.72%
-40.52
-14.32%
-35.45
+68.11%
-111.14
Total Unusual Items Excluding Goodwill
1.91
+104.72%
-40.52
-14.32%
-35.45
+68.11%
-111.14
Special Income Charges
0.18
+100.52%
-34.99
-158.09%
-13.56
0.00
Restructuring And Mergern Acquisition
-0.18
-100.52%
34.99
+158.09%
13.56
0.00
Net Income
-437.99
+16.09%
-521.96
+15.14%
-615.06
-219.24%
515.84
Pretax Income
-437.77
+16.31%
-523.11
+16.73%
-628.19
-183.28%
754.28
Net Non Operating Interest Income Expense
40.24
-43.97%
71.81
-17.45%
86.99
+209.66%
28.09
Net Interest Income
40.24
-43.97%
71.81
-17.45%
86.99
+209.66%
28.09
Interest Income Non Operating
40.24
-43.97%
71.81
-17.45%
86.99
+209.66%
28.09
Interest Income
40.24
-43.97%
71.81
-17.45%
86.99
+209.66%
28.09
Other Income Expense
1.50
+103.51%
-42.74
+3.81%
-44.44
+58.42%
-106.88
Other Non Operating Income Expenses
-0.41
+81.58%
-2.22
+75.30%
-8.99
-311.06%
4.26
Gain On Sale Of Security
1.73
+131.28%
-5.53
+74.74%
-21.89
+80.31%
-111.14
Tax Provision
0.22
+118.95%
-1.15
+91.24%
-13.08
-105.48%
238.44
Tax Rate For Calcs
0.00
+10400.00%
0.00
-90.48%
0.00
-93.35%
0.00
Tax Effect Of Unusual Items
0.40
+595.16%
-0.08
+89.11%
-0.74
+97.88%
-35.12
Net Income Including Noncontrolling Interests
-437.99
+16.09%
-521.96
+15.14%
-615.12
-219.25%
515.84
Net Income From Continuing Operation Net Minority Interest
-437.99
+16.09%
-521.96
+15.14%
-615.06
-219.24%
515.84
Net Income From Continuing And Discontinued Operation
-437.99
+16.09%
-521.96
+15.14%
-615.06
-219.24%
515.84
Net Income Continuous Operations
-437.99
+16.09%
-521.96
+15.14%
-615.12
-219.25%
515.84
Minority Interests
0.00
0.00
-100.00%
0.06
0.00
Normalized Income
-439.50
+8.73%
-481.52
+17.03%
-580.36
-198.06%
591.86
Net Income Common Stockholders
-437.99
+16.09%
-521.96
+15.14%
-615.06
-219.24%
515.84
Diluted EPS
-3.16
+17.49%
-3.83
+16.56%
-4.59
-219.84%
3.83
Basic EPS
-3.16
+17.49%
-3.83
+16.56%
-4.59
-217.99%
3.89
Basic Average Shares
138.52
+1.67%
136.25
+1.58%
134.13
+1.15%
132.61
Diluted Average Shares
138.52
+1.67%
136.25
+1.58%
134.13
-0.50%
134.81
Diluted NI Availto Com Stockholders
-437.99
+16.09%
-521.96
+15.14%
-615.06
-219.24%
515.84
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
1,002.82
-28.31%
1,398.81
-27.11%
1,919.06
-31.51%
2,802.09
Current Assets
514.08
-50.69%
1,042.46
-34.36%
1,588.23
-36.95%
2,519.08
Cash Cash Equivalents And Short Term Investments
467.01
-48.42%
905.35
-40.53%
1,522.41
-36.62%
2,402.04
Cash And Cash Equivalents
232.19
+4.14%
222.95
-7.71%
241.58
-71.53%
848.63
Other Short Term Investments
234.83
-65.59%
682.40
-46.72%
1,280.83
-17.55%
1,553.41
Receivables
—
—
—
0.00
Other Receivables
—
—
—
—
Prepaid Assets
—
—
—
—
Restricted Cash
1.92
-97.85%
89.39
+573.69%
13.27
+4.63%
12.68
Other Current Assets
45.14
-5.41%
47.73
-9.18%
52.55
-49.64%
104.36
Total Non Current Assets
488.74
+37.15%
356.36
+7.71%
330.86
+16.92%
282.98
Net PPE
117.72
-4.19%
122.86
-26.52%
167.20
-11.14%
188.17
Gross PPE
164.88
+3.28%
159.65
-20.61%
201.10
-3.74%
208.91
Accumulated Depreciation
-47.16
-28.20%
-36.78
-8.52%
-33.90
-63.41%
-20.74
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
—
—
—
—
Machinery Furniture Equipment
5.53
+0.93%
5.47
-3.46%
5.67
+5.06%
5.40
Construction In Progress
0.11
-89.39%
1.07
+375.22%
0.23
0.00
Other Properties
103.06
+3.99%
99.11
-13.75%
114.91
-3.51%
119.09
Leases
56.18
+4.05%
53.99
-32.75%
80.29
-4.89%
84.42
Goodwill And Other Intangible Assets
24.79
-1.08%
25.06
-36.61%
39.53
-20.40%
49.66
Goodwill
16.94
+0.00%
16.94
+0.00%
16.94
+0.00%
16.94
Other Intangible Assets
7.85
-3.33%
8.12
-64.06%
22.59
-30.96%
32.72
Investments And Advances
314.57
+65.55%
190.01
+80.49%
105.28
+339.98%
23.93
Other Non Current Assets
31.66
+71.89%
18.42
-2.32%
18.86
-11.16%
21.23
Total Liabilities Net Minority Interest
237.55
-4.38%
248.43
-24.45%
328.82
-54.59%
724.12
Current Liabilities
92.81
-22.44%
119.66
-31.78%
175.41
-65.68%
511.03
Payables And Accrued Expenses
84.02
+0.98%
83.20
-14.83%
97.69
-80.12%
491.38
Payables
11.63
-30.25%
16.67
+7.30%
15.54
-46.98%
29.30
Accounts Payable
9.80
+92.93%
5.08
-19.78%
6.33
-1.37%
6.42
Other Payable
1.82
-84.25%
11.59
+25.94%
9.20
+20.26%
7.65
Current Accrued Expenses
72.39
+8.80%
66.53
-19.01%
82.15
-82.22%
462.07
Total Tax Payable
—
—
0.15
-99.02%
15.23
Income Tax Payable
—
—
0.15
-99.02%
15.23
Current Debt And Capital Lease Obligation
8.80
+13.49%
7.75
-39.75%
12.87
+211.02%
4.14
Current Capital Lease Obligation
8.80
+13.49%
7.75
-39.75%
12.87
+211.02%
4.14
Current Deferred Liabilities
0.00
-100.00%
12.65
-80.50%
64.85
+317.95%
15.52
Current Deferred Revenue
0.00
-100.00%
12.65
-80.50%
64.85
+317.95%
15.52
Other Current Liabilities
—
16.06
—
—
Total Non Current Liabilities Net Minority Interest
144.73
+12.40%
128.77
-16.07%
153.42
-28.01%
213.10
Long Term Debt And Capital Lease Obligation
89.05
-1.20%
90.14
-19.28%
111.67
-9.82%
123.84
Long Term Capital Lease Obligation
89.05
-1.20%
90.14
-19.28%
111.67
-9.82%
123.84
Non Current Deferred Liabilities
—
—
1.53
-97.13%
53.21
Non Current Deferred Revenue
—
—
1.53
-97.13%
53.21
Non Current Deferred Taxes Liabilities
—
—
—
3.25
Other Non Current Liabilities
55.68
+44.14%
38.63
-7.47%
41.74
+15.79%
36.05
Stockholders Equity
765.28
-33.48%
1,150.38
-27.66%
1,590.24
-23.47%
2,077.96
Common Stock Equity
765.28
-33.48%
1,150.38
-27.66%
1,590.24
-23.47%
2,077.96
Capital Stock
0.01
+0.00%
0.01
+7.69%
0.01
+0.00%
0.01
Common Stock
0.01
+0.00%
0.01
+7.69%
0.01
+0.00%
0.01
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
139.47
+1.84%
136.96
+1.62%
134.78
+1.16%
133.24
Ordinary Shares Number
139.47
+1.84%
136.96
+1.62%
134.78
+1.16%
133.24
Additional Paid In Capital
1,965.09
+2.78%
1,911.87
+4.54%
1,828.86
+6.96%
1,709.84
Retained Earnings
-1,197.77
-57.65%
-759.78
-219.47%
-237.82
-163.04%
377.24
Gains Losses Not Affecting Retained Earnings
-2.06
-19.80%
-1.72
-110.67%
-0.81
+91.07%
-9.12
Other Equity Adjustments
-2.06
-19.80%
-1.72
-110.67%
-0.81
+91.07%
-9.12
Total Equity Gross Minority Interest
765.28
-33.48%
1,150.38
-27.66%
1,590.24
-23.47%
2,077.96
Total Capitalization
765.28
-33.48%
1,150.38
-27.66%
1,590.24
-23.47%
2,077.96
Working Capital
421.26
-54.35%
922.80
-34.68%
1,412.82
-29.64%
2,008.05
Invested Capital
765.28
-33.48%
1,150.38
-27.66%
1,590.24
-23.47%
2,077.96
Total Debt
97.85
-0.04%
97.89
-21.40%
124.54
-2.68%
127.97
Capital Lease Obligations
97.85
-0.04%
97.89
-21.40%
124.54
-2.68%
127.97
Net Tangible Assets
740.49
-34.20%
1,125.33
-27.43%
1,550.71
-23.55%
2,028.30
Tangible Book Value
740.49
-34.20%
1,125.33
-27.43%
1,550.71
-23.55%
2,028.30
Available For Sale Securities
314.57
+65.55%
190.01
+80.49%
105.28
+339.98%
23.93
Investmentin Financial Assets
314.57
+65.55%
190.01
+80.49%
105.28
+339.98%
23.93
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-391.78
+12.23%
-446.35
+42.69%
-778.78
-146.82%
1,663.25
Cash Flow From Continuing Operating Activities
-391.78
+12.23%
-446.35
+42.69%
-778.78
-146.82%
1,663.25
Net Income From Continuing Operations
-437.99
+16.09%
-521.96
+15.14%
-615.12
-219.25%
515.84
Depreciation Amortization Depletion
11.68
-19.77%
14.56
-25.15%
19.45
+186.76%
6.78
Depreciation
—
—
18.92
+202.67%
6.25
Amortization Cash Flow
—
—
0.53
-0.19%
0.53
Depreciation And Amortization
11.68
-19.77%
14.56
-25.15%
19.45
+186.76%
6.78
Amortization Of Intangibles
—
—
0.53
-0.19%
0.53
Other Non Cash Items
0.16
-99.61%
40.44
+162.01%
15.43
-94.61%
286.17
Pension And Employee Benefit Expense
—
0.00
—
—
Stock Based Compensation
49.07
-37.45%
78.46
-29.52%
111.32
+9.05%
102.08
Asset Impairment Charge
0.00
-100.00%
14.55
+50.65%
9.66
0.00
Deferred Tax
—
-2.95
-177.42%
-1.06
+93.00%
-15.19
Deferred Income Tax
—
-2.95
-177.42%
-1.06
+93.00%
-15.19
Unrealized Gain Loss On Investment Securities
-1.73
-131.28%
5.53
-74.74%
21.89
-80.31%
111.14
Change In Working Capital
-22.45
+73.06%
-83.32
+74.96%
-332.71
-150.00%
665.37
Change In Receivables
—
-6.51
-1052.74%
-0.56
-100.07%
770.04
Changes In Account Receivables
—
-6.51
-1052.74%
-0.56
-100.07%
770.04
Change In Prepaid Assets
2.08
-52.39%
4.36
-87.99%
36.29
+192.20%
-39.36
Change In Payables And Accrued Expense
-4.51
+93.06%
-65.01
+81.85%
-358.11
-2333.48%
-14.72
Change In Accrued Expense
-9.51
+85.15%
-64.02
+82.16%
-358.84
-2213.18%
-15.51
Change In Payable
5.00
+605.77%
-0.99
-234.97%
0.73
-8.16%
0.80
Change In Account Payable
5.00
+605.77%
-0.99
-234.97%
0.73
-8.16%
0.80
Change In Other Working Capital
—
-53.73
-2191.30%
-2.35
+92.96%
-33.30
Change In Other Current Assets
-12.64
-3681.30%
0.35
-83.66%
2.16
+118.32%
-11.79
Change In Other Current Liabilities
-7.37
+68.00%
-23.03
-76.51%
-13.05
-137.11%
-5.50
Investing Cash Flow
310.37
-37.85%
499.37
+203.33%
164.63
+113.79%
-1,193.46
Cash Flow From Continuing Investing Activities
310.37
-37.85%
499.37
+203.33%
164.63
+113.79%
-1,193.46
Net PPE Purchase And Sale
-4.58
-16.54%
-3.93
+81.79%
-21.57
+68.28%
-68.01
Purchase Of PPE
-4.83
+33.82%
-7.30
+66.16%
-21.57
+68.28%
-68.01
Sale Of PPE
0.25
-92.50%
3.37
0.00
0.00
Capital Expenditure
-4.83
+33.82%
-7.30
+66.16%
-21.57
+68.28%
-68.01
Net Investment Purchase And Sale
314.95
-37.42%
503.30
+170.30%
186.20
+116.54%
-1,125.45
Purchase Of Investment
-886.33
+28.25%
-1,235.34
+38.73%
-2,016.19
-36.51%
-1,476.96
Sale Of Investment
1,201.28
-30.91%
1,738.63
-21.06%
2,202.39
+526.55%
351.51
Financing Cash Flow
3.79
-13.74%
4.39
-41.34%
7.48
-78.48%
34.76
Cash Flow From Continuing Financing Activities
3.79
-13.74%
4.39
-41.34%
7.48
-78.48%
34.76
Net Issuance Payments Of Debt
—
—
-0.29
-10.38%
-0.26
Issuance Of Debt
—
—
—
—
Repayment Of Debt
—
—
-0.29
-10.38%
-0.26
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
—
—
-0.29
-10.38%
-0.26
Net Long Term Debt Issuance
—
—
-0.29
-10.38%
-0.26
Net Common Stock Issuance
—
0.00
0.00
-100.00%
28.46
Common Stock Payments
—
—
—
—
Repurchase Of Capital Stock
—
—
—
—
Proceeds From Stock Option Exercised
4.15
-8.94%
4.55
-41.38%
7.77
+0.14%
7.76
Net Other Financing Charges
-0.36
-118.79%
-0.17
+42.51%
-0.29
+80.30%
-1.46
Changes In Cash
-77.62
-235.23%
57.40
+109.46%
-606.68
-220.24%
504.55
Beginning Cash Position
318.69
+21.97%
261.29
-69.90%
867.97
+138.84%
363.42
End Cash Position
241.07
-24.36%
318.69
+21.97%
261.29
-69.90%
867.97
Free Cash Flow
-396.61
+12.57%
-453.65
+43.32%
-800.36
-150.17%
1,595.25
Income Tax Paid Supplemental Data
—
0.79
-70.63%
2.68
-98.94%
252.03
Amortization Of Securities
9.47
+75.54%
5.40
+161.99%
-8.71
+2.65%
-8.94
Common Stock Issuance
—
0.00
0.00
-100.00%
28.46
Issuance Of Capital Stock
—
0.00
0.00
-100.00%
28.46
Net Preferred Stock Issuance
—
—
—
—
Preferred Stock Issuance
—
—
—
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category